Esperion Therapeutics (ESPR) Fails to deliver data

Key failure to deliver metrics for Esperion Therapeutics:

• Last SEC data release: 2024-11-29
• Last 15 days FTD volume: NZ$1.25 M
• Last 3 months FTD volume: NZ$3.65 M
• Last year FTD volume: NZ$3.65 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013

Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Ultragenyx RARE	NZ$0.87 M	NZ$7.6 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	NZ$7.45 M	NZ$23.02 M	🇺🇸 USA
Pfizer PFE	NZ$48.65 M	NZ$0.35 B	🇺🇸 USA
Regeneron Pharmaceuticals REGN	NZ$13.62 M	NZ$0.10 B	🇺🇸 USA
Amicus Therapeutics FOLD	NZ$0.43 M	NZ$6.21 M	🇺🇸 USA
Lexicon Pharmaceuticals LXRX	NZ$1.6 M	NZ$20.44 M	🇺🇸 USA